000 01535 a2200457 4500
005 20250518041212.0
264 0 _c20200113
008 202001s 0 0 eng d
022 _a1326-5377
024 7 _a10.5694/mja2.50160
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDoyle, Joseph
245 0 0 _aHepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement.
_h[electronic resource]
260 _bThe Medical journal of Australia
_c06 2019
300 _a462-468 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aAustralia
650 0 4 _aFemale
650 0 4 _aHepatitis B
_xprevention & control
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMedical Oncology
_xstandards
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aRisk Factors
650 0 4 _aSocieties, Medical
_xstandards
650 0 4 _aVirus Activation
700 1 _aRaggatt, Michelle
700 1 _aSlavin, Monica
700 1 _aMcLachlan, Sue-Anne
700 1 _aStrasser, Simone I
700 1 _aSasadeusz, Joseph J
700 1 _aHowell, Jessica
700 1 _aHajkowicz, Krispin
700 1 _aNandurkar, Harshal
700 1 _aJohnston, Anna
700 1 _aBak, Narin
700 1 _aThompson, Alexander J
773 0 _tThe Medical journal of Australia
_gvol. 210
_gno. 10
_gp. 462-468
856 4 0 _uhttps://doi.org/10.5694/mja2.50160
_zAvailable from publisher's website
999 _c29705551
_d29705551